Michael Ryskin
Stock Analyst at B of A Securities
(1.39)
# 3,275
Out of 4,711 analysts
34
Total ratings
50%
Success rate
-5.86%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $52 → $54 | $35.54 | +51.94% | 3 | Dec 13, 2024 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $211.06 | -2.40% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $31.67 | +26.30% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $6.86 | +38.48% | 1 | Jun 25, 2024 | |
| MRVI Maravai LifeSciences Holdings | Upgrades: Buy | $10 → $8 | $5.37 | +48.98% | 2 | Dec 12, 2023 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $10.71 | +124.09% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $21.21 | +13.15% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $164.84 | +9.20% | 7 | Nov 4, 2022 | |
| OMIC Singular Genomics Systems | Downgrades: Underperform | $90 | $19.55 | +360.36% | 3 | Aug 10, 2022 | |
| IDXX IDEXX Laboratories | Downgrades: Neutral | $550 → $470 | $412.26 | +14.01% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.03 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $19.44 | +167.49% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $2.99 | +234.45% | 2 | Nov 10, 2021 |
Tempus AI
Dec 13, 2024
Maintains: Neutral
Price Target: $52 → $54
Current: $35.54
Upside: +51.94%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $211.06
Upside: -2.40%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $31.67
Upside: +26.30%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $6.86
Upside: +38.48%
Maravai LifeSciences Holdings
Dec 12, 2023
Upgrades: Buy
Price Target: $10 → $8
Current: $5.37
Upside: +48.98%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $10.71
Upside: +124.09%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $21.21
Upside: +13.15%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $164.84
Upside: +9.20%
Singular Genomics Systems
Aug 10, 2022
Downgrades: Underperform
Price Target: $90
Current: $19.55
Upside: +360.36%
IDEXX Laboratories
May 5, 2022
Downgrades: Neutral
Price Target: $550 → $470
Current: $412.26
Upside: +14.01%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $6.03
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $19.44
Upside: +167.49%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $2.99
Upside: +234.45%